Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1999-04-12
2000-10-31
McKane, Joseph
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514269, 514396, 514438, 514471, 544298, 546333, 5483401, 549 75, 549491, A61K 3134, A61K 31505, C07D21182, C07D23364, C07D30708
Patent
active
061403547
ABSTRACT:
.beta.-Aminotetralin derivatives of the formula: ##STR1## which are ligands for the neuropeptide Y Y5 (NPY5) receptor, methods of preparation and pharmaceutical compositions containing a .beta.-aminotetralin derivative as the active ingredient are described. The .beta.-aminotetralins are useful in the treatment of disorders and diseases associated with NPY receptor subtype Y5.
REFERENCES:
patent: 5026857 (1991-06-01), Schohe et al.
Dax Scott L.
Lovenberg Timothy W.
McNally James
Reitz Allen B.
Youngman Mark A.
McKane Joseph
Ortho-McNeil Pharmaceutical , Inc.
Palo Ralph R.
Solola Taofiq A.
LandOfFree
N-substituted aminotetralins as ligands for the neuropeptide Y Y does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-substituted aminotetralins as ligands for the neuropeptide Y Y, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-substituted aminotetralins as ligands for the neuropeptide Y Y will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2052254